Duane J. Gubler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Duane J. Gubler has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Annelies Wilder-Smith
World Health Organization, Headquarters, Geneva, Switzerland
5 shared publications - Eng Eong Ooi
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore
4 shared publications - Hasitha Tissera
Ministry of Health, Colombo, Sri Lanka
4 shared publications - Abhay P. S. Rathore
Department of Pathology, Duke University Medical Center, Durham, NC, USA
2 shared publications Andrew F. Van Den Hurk
2 shared publications- Ashley Lauren St. John
Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
2 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Springer Nature in npj Viruses
- Vol. 4 (1) , 47
Publisher Correction: Yellow Jack: a modern threat to Asia-Pacific countries?
- 9 October 2026
- Published by Springer Nature in npj Viruses
- Vol. 4 (1) , 47
Open AccessPublisher Correction: Yellow Jack: a modern threat to Asia-Pacific countries?
- Open Access
Proceedings of the 7th Asia Dengue Summit, June 2024
Background: The 7th Asia Dengue Summit (ADS), titled “Road Map to Zero Dengue Death”, was held in Malaysia from 5 to 7 June 2024. The summit was co-organized by Asia Dengue Voice and Action (ADVA); Global Dengue and Aedes-Transmitted Diseases Consortium (GDAC); Southeast Asian Ministers of Education Tropical Medicine and Public Health Network (SEAMEO TROPMED); Fondation Mérieux (FMx); and the International Society for Neglected Tropical Diseases (ISNTD). Objectives: Dengue experts from academia and research, as well as representatives from the Ministries of Health, Regional and Global World Health Organization (WHO), and International Vaccine Institute (IVI), came together to highlight the crucial need for an integrated approach for dengue control and achieve the target of zero dengue deaths. Methods: With more than 50 speakers and delegates from over 28 countries, twelve symposiums, and three full days, the 7th ADS highlighted approaches to curb the growing danger of dengue. The summit included topics ranging from emerging dengue trends, insights from dengue human infection models, the immunology of dengue, and vaccine updates to antivirals and host-directed therapeutics. Conclusions: The 7th Asia Dengue Summit reinforced the importance of an integrated, collaborative approach to dengue prevention and control. By bringing together diverse stakeholders and launching innovative initiatives such as the Dengue Slayers Challenge, the summit advanced the regional and global agenda to achieve zero dengue deaths. The exchange of knowledge and strategies at the summit is expected to contribute significantly to improved dengue management and community engagement in affected regions.
Open AccessProceedings of the 7th Asia Dengue Summit, June 2024
Background: The 7th Asia Dengue Summit (ADS), titled “Road Map to Zero Dengue Death”, was held in Malaysia from 5 to 7 June 2024. The summit was co-organized by Asia Dengue Voice and Action (ADVA); Global Dengue and Aedes-Transmitted Diseases Consortium (GDAC); Southeast Asian Ministers of Education Tropical Medicine and Public Health Network (SEAMEO TROPMED); Fondation Mérieux (FMx); and the International Society for Neglected Tropical Diseases (ISNTD). Objectives: Dengue experts from academia and research, as well as representatives from the Ministries of Health, Regional and Global World Health Organization (WHO), and International Vaccine Institute (IVI), came together to highlight the crucial need for an integrated approach for dengue control and achieve the target of zero dengue deaths. Methods: With more than 50 speakers and delegates from over 28 countries, twelve symposiums, and three full days, the 7th ADS highlighted approaches to curb the growing danger of dengue. The summit included topics ranging from emerging dengue trends, insights from dengue human infection models, the immunology of dengue, and vaccine updates to antivirals and host-directed therapeutics. Conclusions: The 7th Asia Dengue Summit reinforced the importance of an integrated, collaborative approach to dengue prevention and control. By bringing together diverse stakeholders and launching innovative initiatives such as the Dengue Slayers Challenge, the summit advanced the regional and global agenda to achieve zero dengue deaths. The exchange of knowledge and strategies at the summit is expected to contribute significantly to improved dengue management and community engagement in affected regions.
- Open Access
- 24 April 2025
- Published by Springer Nature in npj Viruses
- Vol. 3 (1) , 1-7
Yellow Jack: a modern threat to Asia-Pacific countries?
In 1923, H.R. Carter published a seminal treatise on the possibility of yellow fever virus spreading to the Asia Pacific region, where large numbers of susceptible people were at risk of infection. This paper marks the 100th anniversary of that publication, and posits that, despite many public health advances, global trends increase the likelihood of yellow fever virus geographic spread. Potential reasons for the failure of the virus to spread are discussed.
- 24 April 2025
- Published by Springer Nature in npj Viruses
- Vol. 3 (1) , 1-7
Open AccessYellow Jack: a modern threat to Asia-Pacific countries?
In 1923, H.R. Carter published a seminal treatise on the possibility of yellow fever virus spreading to the Asia Pacific region, where large numbers of susceptible people were at risk of infection. This paper marks the 100th anniversary of that publication, and posits that, despite many public health advances, global trends increase the likelihood of yellow fever virus geographic spread. Potential reasons for the failure of the virus to spread are discussed.
- 9 May 2023
- Published by Springer Nature
- p. 159-185
The Tapestry of Life: Weaving an Arbovirologist
- Open Access
- 19 April 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (4) , 231
Proceedings of the 5th Asia Dengue Summit
The 5th Asia Dengue Summit, themed “Roll Back Dengue”, was held in Singapore from 13 to 15 June 2022. The summit was co-convened by Asia Dengue Voice and Action (ADVA), Global Dengue and Aedes transmitted Diseases Consortium (GDAC), Southeast Asian Ministers of Education Tropical Medicine and Public Health Network (SEAMEO TROPMED), and the Fondation Mérieux (FMx). Dengue experts from academia and research and representatives from the Ministries of Health, Regional and Global World Health Organization (WHO), and International Vaccine Institute (IVI) participated in the three-day summit. With more than 270 speakers and delegates from over 14 countries, 12 symposiums, and 3 full days, the 5th ADS highlighted the growing threat of dengue, shared innovations and strategies for successful dengue control, and emphasized the need for multi-sectoral collaboration to control dengue.
- 19 April 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (4) , 231
Open AccessProceedings of the 5th Asia Dengue Summit
The 5th Asia Dengue Summit, themed “Roll Back Dengue”, was held in Singapore from 13 to 15 June 2022. The summit was co-convened by Asia Dengue Voice and Action (ADVA), Global Dengue and Aedes transmitted Diseases Consortium (GDAC), Southeast Asian Ministers of Education Tropical Medicine and Public Health Network (SEAMEO TROPMED), and the Fondation Mérieux (FMx). Dengue experts from academia and research and representatives from the Ministries of Health, Regional and Global World Health Organization (WHO), and International Vaccine Institute (IVI) participated in the three-day summit. With more than 270 speakers and delegates from over 14 countries, 12 symposiums, and 3 full days, the 5th ADS highlighted the growing threat of dengue, shared innovations and strategies for successful dengue control, and emphasized the need for multi-sectoral collaboration to control dengue.
- Open Access
Th1-Polarized, Dengue Virus-Activated Human Mast Cells Induce Endothelial Transcriptional Activation and Permeability
Dengue virus (DENV), an arbovirus, strongly activates mast cells (MCs), which are key immune cells for pathogen immune surveillance. In animal models, MCs promote clearance of local peripheral DENV infections but, conversely, also promote pathological vascular leakage when widely activated during systemic DENV infection. Since DENV is a human pathogen, we sought to ascertain whether a similar phenomenon could occur in humans by characterizing the products released by human MCs (huMCs) upon direct (antibody-independent) DENV exposure, using the phenotypically mature huMC line, ROSA. DENV did not productively infect huMCs but prompted huMC release of proteases and eicosanoids and induced a Th1-polarized transcriptional profile. In co-culture and trans-well systems, huMC products activated human microvascular endothelial cells, involving transcription of vasoactive mediators and increased monolayer permeability. This permeability was blocked by MC-stabilizing drugs, or limited by drugs targeting certain MC products. Thus, MC stabilizers are a viable strategy to limit MC-promoted vascular leakage during DENV infection in humans.
Open AccessTh1-Polarized, Dengue Virus-Activated Human Mast Cells Induce Endothelial Transcriptional Activation and Permeability
Dengue virus (DENV), an arbovirus, strongly activates mast cells (MCs), which are key immune cells for pathogen immune surveillance. In animal models, MCs promote clearance of local peripheral DENV infections but, conversely, also promote pathological vascular leakage when widely activated during systemic DENV infection. Since DENV is a human pathogen, we sought to ascertain whether a similar phenomenon could occur in humans by characterizing the products released by human MCs (huMCs) upon direct (antibody-independent) DENV exposure, using the phenotypically mature huMC line, ROSA. DENV did not productively infect huMCs but prompted huMC release of proteases and eicosanoids and induced a Th1-polarized transcriptional profile. In co-culture and trans-well systems, huMC products activated human microvascular endothelial cells, involving transcription of vasoactive mediators and increased monolayer permeability. This permeability was blocked by MC-stabilizing drugs, or limited by drugs targeting certain MC products. Thus, MC stabilizers are a viable strategy to limit MC-promoted vascular leakage during DENV infection in humans.
- Open Access
- 5 August 2020
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 103 (2) , 570-571
Preventing Dengue Epidemics during the COVID-19 Pandemic
Preventing Dengue Epidemics during the COVID-19 Pandemic.
- 5 August 2020
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 103 (2) , 570-571
Open AccessPreventing Dengue Epidemics during the COVID-19 Pandemic
Preventing Dengue Epidemics during the COVID-19 Pandemic.
Is Dengvaxia a useful vaccine for dengue endemic areas?
The global spread of epidemic dengue over the past 50 years underscores the critical need for a vaccine. The goal has been a vaccine that provides balanced protection against all four dengue virus serotypes to protect against the severe disease facilitated by antibody dependent enhancement (ADE)—where antibodies, instead of inactivating a virus, facilitate viral entry into host cells. Unfortunately, an effective tetravalent vaccine has been an elusive goal.
Is Dengvaxia a useful vaccine for dengue endemic areas?
The global spread of epidemic dengue over the past 50 years underscores the critical need for a vaccine. The goal has been a vaccine that provides balanced protection against all four dengue virus serotypes to protect against the severe disease facilitated by antibody dependent enhancement (ADE)—where antibodies, instead of inactivating a virus, facilitate viral entry into host cells. Unfortunately, an effective tetravalent vaccine has been an elusive goal.
- 26 August 2019
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 129 (10) , 4180-4193
Dengue virus–elicited tryptase induces endothelial permeability and shock
Dengue virus (DENV) infection causes a characteristic pathology in humans involving dysregulation of the vascular system. In some patients with dengue hemorrhagic fever (DHF), vascular pathology can become severe, resulting in extensive microvascular permeability and plasma leakage into tissues and organs. Mast cells (MCs), which line blood vessels and regulate vascular function, are able to detect DENV in vivo and promote vascular leakage. Here, we showed that an MC-derived protease, tryptase, is consequential for promoting vascular permeability during DENV infection through inducing breakdown of endothelial cell tight junctions. Injected tryptase alone was sufficient to induce plasma loss from the circulation and hypovolemic shock in animals. A potent tryptase inhibitor, nafamostat mesylate, blocked DENV-induced vascular leakage in vivo. Importantly, in 2 independent human dengue cohorts, tryptase levels correlated with the grade of DHF severity. This study defines an immune mechanism by which DENV can induce vascular pathology and shock.
- 26 August 2019
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 129 (10) , 4180-4193
Dengue virus–elicited tryptase induces endothelial permeability and shock
Dengue virus (DENV) infection causes a characteristic pathology in humans involving dysregulation of the vascular system. In some patients with dengue hemorrhagic fever (DHF), vascular pathology can become severe, resulting in extensive microvascular permeability and plasma leakage into tissues and organs. Mast cells (MCs), which line blood vessels and regulate vascular function, are able to detect DENV in vivo and promote vascular leakage. Here, we showed that an MC-derived protease, tryptase, is consequential for promoting vascular permeability during DENV infection through inducing breakdown of endothelial cell tight junctions. Injected tryptase alone was sufficient to induce plasma loss from the circulation and hypovolemic shock in animals. A potent tryptase inhibitor, nafamostat mesylate, blocked DENV-induced vascular leakage in vivo. Importantly, in 2 independent human dengue cohorts, tryptase levels correlated with the grade of DHF severity. This study defines an immune mechanism by which DENV can induce vascular pathology and shock.